IP Library Granted Patent US 9,849,182
Granted Patent B2
US 9,849,182 · App. 14/115,065 · Granted Dec 26, 2017

Wound treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,849,182
App. No.
14/115,065
Granted
Dec 26, 2017
Kind
B2
Abstract

Use of a moulding composition comprising a polymer and a setting agent for wound debridement, wherein said use comprises adding water to said moulding composition to form a moulding fluid, applying said moulding fluid to a surface of a wound, allowing said moulding fluid to set in contact with said surface to form a solid covering on said surface, followed by removing said solid covering from the wound. The alginate composition adheres strongly to bacterial biofilms on the wound, whereby the biofilms are removed with the alginate composition. The moulding composition may be used in conjunction with a staining agent that undergoes a color change in the presence of bacteria or bacterial polysaccharides to show the presence and removal of the biofilm. Also provided are methods of treating wounds using the compositions.

Claims (34)

1. A method for treating a wound, comprising:

adding water to a moulding composition comprising a polymer and a setting agent to form a moulding fluid, wherein the polymer comprises at least one polysaccharide, and the setting agent comprises a divalent metal salt; wherein the polymer and the setting agent are solids, and the moulding fluid comprises a solids to water ratio by weight of between 1:1 and 3:1; applying said moulding fluid to a surface of said wound, allowing said moulding fluid to set in contact with said surface to form a solid covering; and

removing said solid covering from said wound to debride said wound; wherein the removing is performed not more than six hours after the applying.

2. A method according to claim 1 , wherein said polysaccharide is a polyanionic polysaccharide.

3. A method according to claim 2 , wherein said polyanionic polysaccharide is sodium alginate and said setting agent comprises calcium sulphate.

4. A method according to claim 1 , wherein said moulding composition further comprises a filler in an amount of from about 10% to about 70% dry weight basis.

5. A method according to claim 1 , wherein said polymer and said setting agent are in the form of particulate solids in admixture.

6. A method according to claim 1 wherein said moulding composition comprises from about 12% to about 30% dry weight basis of the polymer and from about 12% to about 40% dry weight basis of the setting agent.

7. A method according to claim 1 , wherein said moulding composition further comprises an antimicrobial agent.

8. A method according to claim 1 , wherein said method further comprises applying to said wound a staining agent, wherein said staining agent is adapted to undergo a colour change in the presence of bacteria or bacterial polysaccharides.

9. A method according to claim 8 , wherein the staining agent is a copper phthalocyanine dye.

10. A method according to claim 1 , wherein said step of removing is performed not more than about one hour after said step of applying.

11. A method according to claim 1 , wherein said step of removing is performed not more than about 30 minutes after said step of applying.

12. A method according to claim 1 , wherein said moulding fluid is a chromatic composition that undergoes a colour change when it sets.

13. A method according to claim 1 , wherein said setting agent comprises a calcium salt.

14. A method according to claim 13 , wherein said calcium salt is calcium sulphate or calcium silicate.

15. A method according to claim 13 , wherein said setting agent further comprises a silver salt or zinc salt.

16. A method according to claim 13 , wherein said moulding composition further comprises a retarder adapted to react with said calcium salt to retard the release of calcium.

17. A method according to claim 16 , wherein said retarder is trisodium phosphate.

18. A method according to claim 1 , wherein said moulding composition further comprises one or more plasticisers.

19. A method according to claim 1 , wherein said moulding composition further comprises one or more humectants.

20. A method according to claim 1 , wherein said solid covering has a water content from about 25 wt. % to about 50 wt. %.

21. A method according to claim 8 , wherein said method further comprises applying to said wound the staining agent prior to applying said moulding fluid.

22. A method for debriding a wound, comprising:

applying an aqueous moulding fluid to a surface of said wound, said aqueous moulding fluid comprising (a) a polymer selected from the group consisting of sodium alginate, guar gum, and xanthan gum, (b) a setting agent selected from the group consisting of a calcium salt, a borate salt, and a water soluble galactomannan gum, and (c) a chromatic indicating agent that undergoes a colour change; and (c) a chromatic indicating agent that undergoes a colour change; wherein the polymer and the setting agent are solids, and the moulding fluid comprises a solids to water ratio by weight of between 1:1 and 3:1;

allowing said aqueous moulding fluid to set in contact with said surface to form a solid covering; and

removing said solid covering from said wound to debride said wound, wherein the removing is performed not more than six hours after the applying.

23. A method according to claim 22 , wherein said polymer is sodium alginate and said setting agent comprises calcium sulphate.

24. A method according to claim 22 , wherein said step of removing is performed not more than about one hour after the applying of the moulding fluid.

25. A method according to claim 24 , wherein said step of removing is performed not more than about 30 minutes after the applying of the moulding fluid.

26. A method according to claim 22 , wherein said solid covering has a water content from about 25 wt. % to about 50 wt. %.

27. A method according to claim 22 , wherein said method further comprises applying to said wound a staining agent, wherein said staining agent is adapted to undergo a colour change in the presence of bacteria or bacterial polysaccharides.

28. A method according to claim 22 , wherein said aqueous moulding fluid further comprises an antimicrobial agent.

29. A method according to claim 22 , wherein said chromatic indicating agent is selected from the group consisting of thymolphthalein, phenolphthalein, and mixtures thereof.

Assignments (10)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 6, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; TECHNIMOTION, LLC
Reel/Frame 050945/0278 →
RELEASE OF SECURITY INTEREST Recorded Oct 11, 2019
From: BANK OF AMERICA, N.A.
To: KCI USA, INC.
Reel/Frame 050710/0955 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
SECURITY AGREEMENT Recorded Feb 7, 2017
From: KCI USA, INC., AS GRANTOR
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 041650/0013 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
SECURITY INTEREST Recorded Feb 17, 2016
From: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 037845/0497 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2015
From: SYSTAGENIX WOUND MANAGEMENT IP CO. B.V.
To: KCI USA, INC.
Reel/Frame 035661/0878 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2014
From: MCINROY, LORNA; CLARK, RACHAEL LOUISE; DELBONO, MICHELLE; NISBET, LORRAINE; LOWING, PAUL HOWARD
To: SYSTAGENIX WOUND MANAGEMENT IP CO. BV.
Reel/Frame 032723/0841 →